Category: gene

  • Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

    Sangamo Therapeutics shares decline as Pfizer terminates hemophilia gene therapy agreement on monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) has regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for the treatment of severe-to-moderate hemophilia A that it co-developed and licensed. Pfizer (NYSE: PFE). Pfizer has…

  • Why gene therapy for sickle cell is slow to catch on with patients By Reuters

    Written by Dina Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her first year of school when she returned to the hospital with severe sickle cell pain earlier this month. She does what she can to prevent the bouts of paralysis in her arms, legs…

  • Why gene therapy for sickle cell is slow to catch on with patients By Reuters

    Written by Dina Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her first year of school when she returned to the hospital with severe sickle cell pain earlier this month. She does what she can to prevent the bouts of paralysis in her arms, legs…

  • Vertex sues US over fertility support program for Casgevy gene editing therapy By Reuters

    (Reuters) – Vertex Pharmaceuticals Inc. sued the U.S. Department of Health and Human Services on Monday seeking a court declaration that its fertility support program for patients prescribed its gene-editing treatment Kasgevi does not violate federal anti-kickback laws. Casgevy is approved to treat two genetic disorders — sickle cell disease…

  • Vertex sues US over fertility support program for Casgevy gene editing therapy By Reuters

    (Reuters) – Vertex Pharmaceuticals Inc. sued the U.S. Department of Health and Human Services on Monday seeking a court declaration that its fertility support program for patients prescribed its gene-editing treatment Kasgevi does not violate federal anti-kickback laws. Casgevy is approved to treat two genetic disorders — sickle cell disease…